Education
About Us
Working with TipRanks
Follow Us
NovoCure Ltd. (NVCR)
NASDAQ:NVCR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 605.22M | $ 509.34M | $ 537.84M | $ 535.03M | $ 494.37M |
| Gross Profit | $ 468.04M | $ 381.06M | $ 422.97M | $ 420.15M | $ 387.87M |
| Operating Income | $ -170.50M | $ -232.87M | $ -89.52M | $ -44.33M | $ 30.40M |
| EBITDA | $ -109.58M | $ -177.45M | $ -67.89M | $ -38.38M | $ 44.83M |
| Net Income | $ -168.63M | $ -207.04M | $ -92.53M | $ -58.35M | $ 19.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 959.87M | $ 910.62M | $ 969.42M | $ 938.51M | $ 854.08M |
| Total Assets | $ 1.24B | $ 1.15B | $ 1.19B | $ 1.14B | $ 1.05B |
| Total Debt | $ 683.35M | $ 596.24M | $ 584.27M | $ 581.90M | $ 450.68M |
| Net Debt | $ 519.59M | $ 355.42M | $ 468.94M | $ 372.29M | $ 204.51M |
| Total Liabilities | $ 880.61M | $ 783.63M | $ 750.48M | $ 729.00M | $ 575.46M |
| Stockholders' Equity | $ 360.18M | $ 362.50M | $ 441.17M | $ 410.49M | $ 476.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -69.22M | $ -100.43M | $ 9.43M | $ 58.59M | $ 84.18M |
| Operating Cash Flow | $ -26.37M | $ -73.34M | $ 30.79M | $ 82.76M | $ 99.15M |
| Investing Cash Flow | $ -140.24M | $ 184.15M | $ -139.96M | $ -144.83M | $ -472.85M |
| Financing Cash Flow | $ 90.31M | $ 15.79M | $ 15.49M | $ 25.70M | $ 440.21M |